Related Experiment Video
Updated: Mar 11, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?
B Edwards1, R Andini2, S Esposito3
1Medical Microbiology Department, Royal Infirmary of Edinburgh, 51 Little France Crescent, Dalkeith Road, Edinburgh EH16 4SA, UK.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) infection continues to be a substantial global problem with significant associated morbidity and mortality. This review summarises the discussions that took place at the 4th MRSA Consensus Conference in relation to the current treatment options for serious MRSA infections and how to optimise whichever therapy is embarked upon. It highlights the many challenges faced by both the laboratory and clinicians in the diagnosis and treatment of MRSA infections.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Mitral Stenosis III: Medical Management
Development of Antibiotic Resistance
Endocarditis III: Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

